von Tobias Borgers | Mai 10, 2022 | Continuous Manufacturing, Markt
Thorough supply chain management and end-to-end quality assurance are of utmost value to pharma compliance and patient safety. A significant part of maintaining quality involves ensuring standards are upheld along the global supply chain, regarding active...
von Tobias Borgers | Mai 4, 2022 | Medipak
New location in Korea: Körber further expands presence of pharma portfolio in AsiaHamburg, Germany/ Seoul, Korea, 01 April, 2022. Körber Korea co., Ltd. Is the Körber Group’s new location in Seoul, which will commence operations effective April 01, 2022. With...
von Tobias Borgers | Mai 4, 2022 | Markt
Interest in oligonucleotide therapeutics has grown, as has the market demand, since their emergence as a new drug modality two decades ago. Initially focusing on rare diseases, oligonucleotide therapeutics are moving into more common chronic indications like asthma,...
von Tobias Borgers | Mai 4, 2022 | Boehringer
Bruck an der Leitha/Wien (A) Das weltweit erfolgreiche Unternehmen Boehringer Ingelheim hat entschieden, eine neue Produktionsstätte in Niederösterreich zu errichten. Damit werden in Zukunft in Bruck an der Leitha Medikamente gegen Schlaganfall, Krebs und...
von Tobias Borgers | Apr. 15, 2022 | Medipak
Neuer Standort in Korea: Körber baut Präsenz des Pharma-Portfolios in Asien weiter aus Hamburg, Deutschland/ Seoul, Korea, 01. April 2022. Körber Korea co., Ltd. heißt der neue Standort des Körber-Konzerns in Seoul, der zum 01. April 2022 seine Arbeit aufnimmt. Mit...
